FdaApplication
ANDA 204621
Identifiers
- fda_app_no: ANDA204621
Properties
| Property | Value |
|---|---|
| applicant_name | ALVOGEN INC |
| application_type | ANDA |
| approval_date | 2015-07-10 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | 400MG | TABLET, EXTENDED RELEASE;ORAL |
| NEVIRAPINE | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
2 products